MOTEGRITY
These highlights do not include all the information needed to use MOTEGRITY safely and effectively. See full prescribing information for MOTEGRITY. MOTEGRITY (prucalopride) tablets, for oral use Initial U.S. Approval: 2018
bca1e4c6-4b2b-4876-8ab3-654629c4ff1b
HUMAN PRESCRIPTION DRUG LABEL
Oct 28, 2022
Takeda Pharmaceuticals America, Inc.
DUNS: 039997266
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
PRUCALOPRIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
PRUCALOPRIDE
Product Details
FDA regulatory identification and product classification information